BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 16814354)

  • 21. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.
    Fertey J; Hurst J; Straub E; Schenker A; Iftner T; Stubenrauch F
    J Virol; 2011 Mar; 85(6):2918-26. PubMed ID: 21191025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.
    Fertey J; Ammermann I; Winkler M; Stöger R; Iftner T; Stubenrauch F
    J Virol; 2010 Sep; 84(18):9505-15. PubMed ID: 20631145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.
    MacDermed DM; Khodarev NN; Pitroda SP; Edwards DC; Pelizzari CA; Huang L; Kufe DW; Weichselbaum RR
    BMC Med Genomics; 2010 May; 3():16. PubMed ID: 20459602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.
    Herdman MT; Pett MR; Roberts I; Alazawi WO; Teschendorff AE; Zhang XY; Stanley MA; Coleman N
    Carcinogenesis; 2006 Nov; 27(11):2341-53. PubMed ID: 16973673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.
    Pett MR; Herdman MT; Palmer RD; Yeo GS; Shivji MK; Stanley MA; Coleman N
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3822-7. PubMed ID: 16505361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration.
    Lace MJ; Anson JR; Haugen TH; Dierdorff JM; Turek LP
    Carcinogenesis; 2015 Jan; 36(1):151-9. PubMed ID: 25416558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes.
    Karstensen B; Poppelreuther S; Bonin M; Walter M; Iftner T; Stubenrauch F
    Virology; 2006 Sep; 353(1):200-9. PubMed ID: 16814354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.
    Thierry F
    Virology; 2009 Feb; 384(2):375-9. PubMed ID: 19064276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV: from infection to cancer.
    Stanley MA; Pett MR; Coleman N
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
    Yugawa T; Kiyono T
    Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Virological and carcinogenic aspects of HPV].
    Prétet JL; Charlot JF; Mougin C
    Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.